THE Therapeutic Goods
Administration has published
extension of indications for five
registered medicines.
Mundipharma’s Targin
(oxycodone hydrochloride and
naloxone hydrochloride) has an
extended listing to include restless
legs syndrome under specific
conditions.
Top seller Humira (adalimumab)
from Abbvie has broadened
indications in immunological
diseases and Allergan’s Latisse
(bimatoprost) can now treat
hypotrichosis of the eye lashes.
Utrogestan (progesterone) by
Besins Healthcare and Descovy
(emtricitabine and tenofovir
alafenamide fumarate) from Gilead
have also gained extensions of
indication in July.
Visit www.tga.gov.au for full
details on the indications.The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jul 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jul 16
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.